20/20 Biolabs Inc. (AIDX) vs Processa Pharmaceuticals, Inc. (PCSA)

A side-by-side comparison of 20/20 Biolabs Inc. and Processa Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
20/20 Biolabs Inc. logo
AIDX
20/20 Biolabs Inc.
$4M
$0.35HealthcareDelayed quote: Oct 6, 2026, 12:56 PM EDT
Processa Pharmaceuticals, Inc. logo
PCSA
Processa Pharmaceuticals, Inc.
$4M
$1.47HealthcareDelayed quote: Oct 6, 2026, 12:59 PM EDT

Total return — AIDX vs PCSA

growth of $100 · dividends reinvested · last 1y
AIDX -98.5% (-98.5%/yr)PCSA -31.6% (-31.6%/yr)PCSA compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100$1$68
AIDX PCSA

AIDX vs PCSA: by the numbers

  • •AIDX is the larger company ($4M vs $4M market cap).
  • •Both run net losses; PCSA's is the smaller (0.00% vs -285.00% net margin).

Metrics side by side

Valuation

MetricAIDXPCSA
P/S ratio2.08N/A
P/B ratio2.61N/A

Profitability

MetricAIDXPCSA
Gross margin31.52%0.00%
Operating margin-162.87%0.00%
Net margin-285.00%0.00%
ROE-184.04%N/A
ROIC-116.89%N/A

Growth (annualized)

MetricAIDXPCSA
Revenue CAGR (5Y)-2.58%N/A
Total return CAGR (5Y)N/A-79.32%

Go deeper

Full AIDX analysisFull PCSA analysisInteractive comparison tool

Dig into the metrics

20/20 Biolabs ROEProcessa Pharmaceuticals ROE20/20 Biolabs operating marginProcessa Pharmaceuticals operating margin20/20 Biolabs revenue growthProcessa Pharmaceuticals revenue growth20/20 Biolabs free cash flowProcessa Pharmaceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.